Society of skeletal radiology member utilization and performance of whole-body MRI in adults

Feldhaus, Jacob M; Garner, Hillary W.; Wessell, Daniel E.

doi:10.1007/s00256-020-03471-3

Cited by 3 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Different MRI sequences are being used based on imaging protocols of the radiology department [ 21 , 22 , 23 , 24 ]. Fat-suppressed T2-weighted (FS T2W), Short Tau Inversion recovery (STIR), and T1-weighted (T1W) MRI sequences are most commonly utilized for MM [ 23 , 24 , 25 , 26 , 27 ]. The signal intensity on FS T2W and STIR images correlates with the plasma cell concentration in the bone marrow.…”

Section: Mrimentioning

confidence: 99%

Advanced Imaging in Multiple Myeloma: New Frontiers for MRI

et al. 2022

View full text Add to dashboard Cite

Plasma cell dyscrasias are estimated to newly affect almost 40,000 people in 2022. They fall on a spectrum of diseases ranging from relatively benign to malignant, the malignant end of the spectrum being multiple myeloma (MM). The International Myeloma Working Group (IMWG) has traditionally outlined the diagnostic criteria and therapeutic management of MM. In the last two decades, novel imaging techniques have been employed for MM to provide more information that can guide not only diagnosis and staging, but also treatment efficacy. These imaging techniques, due to their low invasiveness and high reliability, have gained significant clinical attention and have already changed the clinical practice. The development of functional MRI sequences such as diffusion weighted imaging (DWI) or intravoxel incoherent motion (IVIM) has made the functional assessment of lesions feasible. Moreover, the growing availability of positron emission tomography (PET)–magnetic resonance imaging (MRI) scanners is leading to the potential combination of sensitive anatomical and functional information in a single step. This paper provides an organized framework for evaluating the benefits and challenges of novel and more functional imaging techniques used for the management of patients with plasma cell dyscrasias, notably MM.

show abstract

Section: Mrimentioning

confidence: 99%

Advanced Imaging in Multiple Myeloma: New Frontiers for MRI

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Comparatively, whole-body MRI with diffusion weighted imaging is the most sensitive for BMT and allows for the earliest detection of focal disease in the form of cellular infiltration, even before trabecular or cortical destruction [19]. Unfortunately, there remain barriers to whole-body MR's wide implementation into routine clinical practice due to its cost, acquisition time, and challenges with billing and reimbursement [20]. If whole-body MRI is not available, MRI of the spine and pelvis is considered a suitable alternative [19].…”

Section: Bone Marrow Tumorsmentioning

confidence: 99%

Adult Tumors of Soft Tissue, Bone, and Bone Marrow: What the Clinician Wants to Know

Garner

Murphey

2021

IDKD Springer Series

Self Cite

View full text Add to dashboard Cite

The perceived value of the radiologist to the healthcare team hinges on the accuracy of image interpretation and the quality, clarity, and consistency of the associated report. A thorough understanding of what clinicians want to know from imaging of soft tissue, bone, and bone marrow tumors allows the radiologist to better analyze and communicate the relevant findings using a common multidisciplinary language. Inclusion in the report of a detailed patient history relative to the tumor is also important in that it indicates to the clinician and the patient a clear engagement in the patient’s care and an insight into the desired imaging objectives. With these tenets in mind, this review highlights what clinicians want to know from imaging for soft tissue, bone, and bone marrow tumors.

show abstract